Previous Page  16 / 21 Next Page
Information
Show Menu
Previous Page 16 / 21 Next Page
Page Background

Page 40

Notes:

allied

academies

August 14-16, 2017 | Toronto, Canada

BRAIN DISORDERS AND DEMENTIA CARE

4

th

International Conference on

Neurosurg, an open access journal

ISSN: 2471-9633

A

lzheimer’s disease (AD) is the most common cause of

dementia. It is a progressive neurodegenerative disorder

that leads to nerve cell death throughout the brain. It is a

growing public health problem with major socioeconomic

burden. The progression of AD is time dependent, it spread

spontaneously but there is a lack of data in understanding

its progression. By identifying the stage of the disease,

prediction is possible, symptoms can be expected and the

power to find real treatment will be enhanced.

Modeling stages of Alzheimer’s disease in rats:

Aluminum

(Al) has been implicated in aging related changes. It crosses

the blood brain barrier and has been found in both senile

plaques and neurofibrillary tangles-bearing neurons in

the brains of AD patients. Its neurotoxicity in animals has

been clearly established and shown to be involved in the

etiology of AD. To establish a model mimics AD in rats and

for modeling stages of the disease as well as to determine its

progression in the brain in response to time, different doses

of aluminum can be used for different periods. It was found

that 70 mg/kg of aluminum for 6 weeks represents the ideal

model that mimics AD in rats. The progression of the disease

is time dependent and just starts spread spontaneously

without more aluminum exposure.

Risk Factors and Protection of Alzheimer’s disease:

Major

attention has been paid to AD risk factors; some risk factors

can be changed while others cannot. Modifiable risk factors

include stress, heavy smoking, excessive alcohol drinking,

depression, low education, cognitive and physical inactivity

as well as malnutrition. Exposure to stress represents a risk

factor in both induction and progression of AD especially in

thedevelopedcountries,whileproteinmalnutrition increases

both severity as well as progression of AD and represents

a socioeconomic problem especially in the developing

countries. There are many medical conditions that increase

the chance of developing dementia especially Parkinson's

disease and diseases related to learning disabilities. For the

complexity of the mechanisms involved in AD, multi-target

directed strategies by using combined therapies together

with physical and mental activities represent new promising

strategies for reduction of AD prevalence and for providing

marked symptomatic and disease modifying benefits

especially with risk factors. However, further researches are

needed to improve the quality of evidence associated with

reduction of AD prevalence and incidence.

Speaker Biography

Azza A Ali has completed her PhD specialized in Pharmacology and Toxicology from

Faculty of Pharmacy, Cairo University. Her postdoctoral studies included different

scientific aspects related to her specialization field with giving especial interest to

researches of neuropharmacology and psychopharmacology; she also developed

research line of behavioral pharmacology in Egypt. She is member of many scientific

societies in Egypt as well as of (AAPS) American Association of Pharmaceutical

Scientists (2002) and (ISTAART) The Alzheimer's Association International Society to

Advance Alzheimer's Research and Treatment (2016). She published more than 50

papers in reputed journals, supervised and discussed more than 80 PhD, MSc thesis

and actively participated by oral and posters presentations at many international

conferences especially on Alzheimer's disease & Dementia as Dementia 2015,

2016 and Alzheimer's Association International Conference (AAIC 2016). She has

many appreciation certificates and certificate of best presentation award at 19th

International Conference on Environmental Pollution and Pollution Control (ICEPPC

2017). Now she is a Head of Pharmacology and Toxicology Department at Al-Azhar

University and she sacrifices great effort hoping to find real treatment that can prevent

or delay the progression of Alzheimer's disease especially in the high-risk individuals

focusing on depression, stress and malnutrition.

e:

azzamoro@gmail.com

Aluminum Induced Alzheimer’s disease: Induction, Progression, Risk Factors and Protection

Azza A Ali

Al-Azhar University, Egypt

Azza A Ali, Neurosurg 2017, 2:2

DOI: 10.21767/2471-9633-C1-005